Literature DB >> 22042369

Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.

Sheng-Jun Liao1, Yuan-Hong Zhou, Ye Yuan, Dong Li, Feng-Hua Wu, Qi Wang, Jian-Hua Zhu, Bin Yan, Jing-Jing Wei, Gui-Mei Zhang, Zuo-Hua Feng.   

Abstract

Triggering of Toll-like receptor 4 (TLR4) on tumor cells has been found to promote tumor progression by promoting tumor cell proliferation and survival. So far, however, the effect of TLR4 signaling on tumor metastasis has not been well elucidated. Here, we report that triggering of TLR4 on metastatic breast cancer cells could reciprocally regulate the expression of αvβ3 and the expressions of TPM1 and maspin, and promote αvβ3-mediated adhesion and invasive migration of the cells. In metastatic breast cancer cells, TLR4 signaling increased the expression of integrin αvβ3 by activating NF-κB, resulting in the increased adhesion capacity of tumor cells to the ligand for αvβ3, and the increased polymerization of actin and production of MMP-9 in tumor cells in response to ECM. HoxD3 was required for the up-regulation of αv and β3 expressions by NF-κB. Moreover, TLR4 signaling increased the expression of miR-21 in breast cancer cells by activating NF-κB. Accordingly, the expressions of TPM1 and maspin were decreased at protein level, whereas the transcription activity of these genes was not influenced. Consistent with the promoting effect on αvβ3-mediated adhesion and invasive migration, TLR4 signaling promoted the arrest of metastatic breast cancer cells in circulation and following invasion. The effect of TLR4 signaling could be abrogated by inhibiting NF-κB. These findings suggest that metastatic breast cancer cells could acquire higher metastatic potential due to triggering of TLR4 and activation of NF-κB in the cells, and that both TLR4 and NF-κB could be therapeutic targets for preventing metastasis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042369     DOI: 10.1007/s10549-011-1844-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  37 in total

1.  TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation.

Authors:  Sheng-Jun Liao; Jing Luo; Dong Li; Yuan-Hong Zhou; Bin Yan; Jing-Jing Wei; Jian-Cheng Tu; Yi-Rong Li; Gui-Mei Zhang; Zuo-Hua Feng
Journal:  J Cell Commun Signal       Date:  2019-02-09       Impact factor: 5.782

2.  Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells.

Authors:  C Luo; Y Shu; J Luo; D Liu; D-S Huang; Y Han; C Chen; Y-C Li; J-M Zou; J Qin; Y Wang; D Li; S-S Wang; G-M Zhang; J Chen; Z-H Feng
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

3.  NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer.

Authors:  Xiyu Liu; Changyan Pei; Song Yan; Guifeng Liu; Gang Liu; Wenqing Chen; Youbin Cui; Yahui Liu
Journal:  Tumour Biol       Date:  2015-01-16

4.  Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.

Authors:  Bao-Ping Luo; Jing Luo; Yi-Bing Hu; Xiao-Wei Yao; Feng-Hua Wu
Journal:  Curr Med Sci       Date:  2018-06-22

5.  Modifications of disulfide bonds in breast cancer cell migration and invasiveness.

Authors:  Marcin Popielarski; Halszka Ponamarczuk; Marta Stasiak; Cezary Watała; Maria Świątkowska
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

6.  TLR4 is a novel determinant of the response to paclitaxel in breast cancer.

Authors:  Sandeep Rajput; Lisa D Volk-Draper; Sophia Ran
Journal:  Mol Cancer Ther       Date:  2013-05-29       Impact factor: 6.261

7.  Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cells.

Authors:  Geun-Soo Park; Jae-Hong Kim
Journal:  Oncotarget       Date:  2015-03-20

8.  FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.

Authors:  Kuppusamy Balamurugan; Shikha Sharan; Kimberly D Klarmann; Youhong Zhang; Vincenzo Coppola; Glenn H Summers; Thierry Roger; Deborah K Morrison; Jonathan R Keller; Esta Sterneck
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Links between Toll-like receptor 4 and breast cancer.

Authors:  Abubakr Ahmed; H Paul Redmond; Jiang Huai Wang
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

10.  TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.

Authors:  Yuan-Hong Zhou; Sheng-Jun Liao; Dong Li; Jing Luo; Jing-Jing Wei; Bin Yan; Rui Sun; Yu Shu; Qi Wang; Gui-Mei Zhang; Zuo-Hua Feng
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.